Fox Run Management, L.L.C. I Teos Therapeutics, Inc. Transaction History
Fox Run Management, L.L.C.
- $433 Million
- Q3 2024
A detailed history of Fox Run Management, L.L.C. transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Fox Run Management, L.L.C. holds 19,263 shares of ITOS stock, worth $139,078. This represents 0.05% of its overall portfolio holdings.
Number of Shares
19,263
Previous 12,018
60.28%
Holding current value
$139,078
Previous $178,000
10.11%
% of portfolio
0.05%
Previous 0.03%
Shares
4 transactions
Others Institutions Holding ITOS
# of Institutions
166Shares Held
36.6MCall Options Held
1.95MPut Options Held
374K-
Black Rock Inc. New York, NY3.73MShares$26.9 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.18MShares$23 Million0.45% of portfolio
-
Boxer Capital, LLC San Diego, CA2.95MShares$21.3 Million1.6% of portfolio
-
Mpm Asset Management LLC Cambridge, MA2.74MShares$19.8 Million19.24% of portfolio
-
Tang Capital Management LLC San Diego, CA2.41MShares$17.4 Million2.09% of portfolio
About iTeos Therapeutics, Inc.
- Ticker ITOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,575,300
- Market Cap $257M
- Description
- Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...